DiNuzzo Private Wealth’s ADMA Biologics ADMA Stock Holding History

DiNuzzo Private Wealth’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34	Sell	4 -13	-76%	-$119	﹤0.01%	1324
2026 Q1	$154	Sell	17 -6	-26%	-$95	﹤0.01%	1257
2025 Q4	$420	Buy	23 +2	+10%	+$34	﹤0.01%	1130
2025 Q3	$363	Sell	21 -11	-34%	-$189	﹤0.01%	1167
2025 Q2	$583	Buy	32 +4	+14%	+$82	﹤0.01%	1028
2025 Q1	$556	Hold	28	–	–	﹤0.01%	1012
2024 Q4	$481	Buy	28 +23	+460%	+$433	﹤0.01%	1093
2024 Q3	$100	Buy	+5	New	+$78	﹤0.01%	1369

Other funds holding ADMA

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

DiNuzzo Private Wealth's ADMA Position: Q2 2026 in Review

DiNuzzo Private Wealth reduced its ADMA Biologics (ADMA) stake by 76% in Q2 2026, selling an estimated $119 and leaving 4 shares worth $34. The position accounts for ﹤0.01% of the portfolio, ranked #1324.

DiNuzzo Private Wealth first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $583 in Q2 2025. 69 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

DiNuzzo Private Wealth held 4 shares of ADMA Biologics worth $34 as of Q2 2026.
DiNuzzo Private Wealth sold 13 ADMA Biologics shares in Q2 2026, an estimated $119.
ADMA Biologics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #1324 holding.
DiNuzzo Private Wealth first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
DiNuzzo Private Wealth's ADMA Biologics position peaked at $583 in Q2 2025.
69 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.